Author: dxnimble

03Sep

NIMBLE and The European Safe Hearts Plan: Towards a More Proactive Cardiovascular Care
In December 2025, the European Commission unveiled the Safe Hearts Plan, the first comprehensive EU-wide framework dedicated to cardiovascular health.1 Its ambition is significant: to reduce premature cardiovascular mortality by 25% by 2035. With cardiovascular disease still responsible for around 1.7 million deaths every year in the EU and an estimated annual economic burden of €282 billion, achieving this goal will require more than treating cardiovascular disease when complications occur. It will also require a stronger focus on prevention, early detection and smarter use of healthcare resources. 1 At NIMBLE …
24Jul

NIMBLE I
NIMBLE-I  We are excited to share that NIMBLE-I, our first-in-human clinical study, is now officially completed.   Fifty-six patients were enrolled at the Hospital Universitari Germans Trias i Pujol (Can Ruti) in Badalona, Spain, marking an important milestone in the journey of the WAEVE® System from laboratory prototype to clinical reality.  The Problem  Every year, hundreds of thousands of patients undergo coronary stent implantation to treat blocked arteries. While stents are life-saving, living with one is not without uncertainty. In-stent restenosis (ISR), the re-narrowing of the artery inside the stent, affects between 5% and 10% of all patients with a stent. Aside restenosis, stent fractures and other structural complications add …

Introducing Montse Gutiérrez: Regulatory Affairs and Quality Assurance Director
At NIMBLE, every team member brings a distinct perspective to the table. Today, we’re spotlighting Montse Gutiérrez, our RAQA Director, who joined us in April 2025. Her role sits at the crossroads of innovation and compliance, to ensure NIMBLE’s vision can actually reach patients, legally, safely, and credibly. Since joining, Montse has established the quality and regulatory framework that underpins product development, clinical investigations, and the company’s path toward global market access. That includes early involvement in the FDA Breakthrough Device Designation program and the regulatory work required to obtain …

Introducing David Anguiano: Senior Telecommunications Engineer
At NIMBLE, every team member brings a distinct perspective to the table. Today, we’re spotlighting David Anguiano, our Senior Telecommunications Engineer, who works at the intersection of radio frequency (RF) engineering and medical technology, a combination that sits at the heart of what NIMBLE is building. Since joining the team, David has taken on the electromagnetic and antenna design side of the technology, covering everything from simulation and microwave measurements to signal analysis in real-world testing conditions. One of his most significant contributions has been the redesign of the transducer …

Introducing Pol Gómez: Chief Medical Officer
At NIMBLE, every team member contributes uniquely to our mission of turning innovative ideas into real clinical solutions. Today, we’re spotlighting Pol Gómez, our Chief Medical Officer, who joined NIMBLE in January 2023. Pol brought with him a wealth of experience from both the clinical and research worlds, combining his work in cardiology clinical trials with his background as an administrator in the Cardiology Research Group (ICREC) at the IGTP Foundation, where NIMBLE was born.  One of his key contributions has been coordinating the process that led to the AEMPS …

From your kitchen to Clinical Settings
Microwaves don't just heat food: they detect tumors, guide cancer therapies, and monitor stents with zero radiation. Discover how this technology is reshaping modern medicine. The solution: Waeve system.

Welcoming Prof. Dr. Morton J. Kern to our Team
NIMBLE is delighted to announce that Prof. Dr. Morton J. Kern, MD, a leading clinician in interventional cardiology, has joined our Medical Advisory Board. His expertise will play a pivotal role in guiding our clinical strategy, particularly as we prepare for entry into the US market and pursue FDA approval.   Background: Dr. Kern is a Professor of Medicine at the University of California, Irvine in the Division of Cardiology. He is also Chief of Cardiology at the Long Beach Veterans Administration Medical Center. Dr Kern received his medical degree …

How Long Do Coronary Stents Last and Factors That Influence Their Lifespan
Coronary stents are life-saving 'implants used to treat coronary artery disease (CAD) by maintaining open arteries and ensuring adequate blood flow to the heart. Understanding the longevity of heart stents and the factors that influence their lifespan is crucial for patients and healthcare providers to manage expectations and optimize outcomes. (E.g.) Published 18 June 2024 Reviewed by: Oriol Rodriguez, MD. Interventional Cardiologist at Hospital Germans Tries i Pujol, Badalona, ES. How Long Do Coronary Stents Last? Factors That Influence Their Lifespan Coronary stents are life-saving implants used to treat coronary …
angiography alternative29Nov

Non-invasive Alternatives to Angiography: The Main Benefits
Currently, in today’s technology landscape, there is no easy way to ensure that a stent is functioning properly without resorting to an invasive procedure, the coronary angiography. To learn more about coronary angiography check out our previous article here. This procedure is not only costly but could also pose risks to the patient. That is why the medical community is eager to incorporate new technologies that offer non-invasive stent monitoring. This article will describe the current methods for diagnosing coronary stent malfunctions and highlight their main advantages and limitations. What …

NIMBLE Diagnostics CTO Susana Amorós: Leader of Innovation
NIMBLE Diagnostics has a strong collection of leaders steering its development and innovation as its technology succeeds expectations. Their CTO, Susana Amorós, sat down to discuss what brought her to the project, the next steps, and the inspiration that brought her to change lives. Amorós began her studies at UPC studying telecommunications engineering. However, during her last year, she discovered her passion — working in the medical sector of her field. With her degree, she would be able to aid in the design, testing, and manufacturing of medical equipment. Understanding …
nimble-diagnostics-stent11Jul

NIMBLE Diagnostics at Las Vegas Conference
MWC Conference in Las Vegas NIMBLE Diagnostics is proud to announce its invitation to the MWC Conference in Las Vegas. The MWC Conference celebrates innovation and human progress in technology development. NIMBLE Diagnostics plans to attend September 26-28th, 2023 to highlight its innovative technology and to network with other companies that are changing the game of the technology field as science continues to evolve. Not only will it offer an opportunity to share the revolutionary technology NIMBLE has been working on, but MWC Las Vegas will also allow NIMBLE access …

NIMBLE Diagnostics provides peace of mind to patients and clinicians by developing innovative medical devices. The device is currently in the regulatory submission phase.

  • IGTP Institut Germans Tries i Pujol
     Camí de les Escoles, s/n
    08916 Badalona, Barcelona
Explore
Contact us